| Page 2033 | Kisaco Research
 

Matthew Wiseman

Partner
Alantra

Matthew is a key member of our Consumer sector team in the UK and within our international partnership. He works closely with business owners and management teams in the personal care and beauty sectors, as well as supporting financial sponsors, whether that be the generation of off-market opportunities, buy-side advice or maximising value in sales processes.

Recent deals include advising Piper on its investment in Neom Organics.

Matthew Wiseman

Partner
Alantra

Matthew Wiseman

Partner
Alantra

Matthew is a key member of our Consumer sector team in the UK and within our international partnership. He works closely with business owners and management teams in the personal care and beauty sectors, as well as supporting financial sponsors, whether that be the generation of off-market opportunities, buy-side advice or maximising value in sales processes.

Recent deals include advising Piper on its investment in Neom Organics.

As the co-founder of a specialist M&A advisor, Matthew has advised many multi-national and private owners of household, personal care and beauty assets globally, including the sales of market-leading brands including Bulldog, REN Skincare, Batiste Dry Shampoo and Liz Earle.

Matthew held positions at PwC and Close Brothers Corporate Finance, where his focus was on the consumer products, travel, food and pubs sectors advising privately owned businesses, mid-market private equity and major public companies divesting non-core divisions.  

Matthew graduated with a degree in law from King’s College, London before qualifying as a chartered accountant with PwC.

He has a wife and two young children who keep him busy outside of work, fitting in training when possible to maintain the last memories of sporting prowess.

Finalistas do expositor 2018
Finalistas de la Exposicion 2018
Showcase Finalists 2018
 

Dana Hosseini

CEO and Co-Founder
ProdermIQ, Inc

A serial entrepreneur who has managed and co-founded a number of genomics-based companies including, ProdermIQ, Iceland Genomics and DiThera. Mr. Hosseini's skills in international medical device/diagnostic sales and marketing were developed at Abbott Laboratories, Ortho Clinical Diagnostics (Johnson & Johnson) and Sequenom, where he held executive and management positions in business development, and sales and marketing functions. He has 25+ years of extensive experience working with global biotech, pharmaceutical companies and healthcare providers. He received both his B.Sc.

Dana Hosseini

CEO and Co-Founder
ProdermIQ, Inc

Dana Hosseini

CEO and Co-Founder
ProdermIQ, Inc

A serial entrepreneur who has managed and co-founded a number of genomics-based companies including, ProdermIQ, Iceland Genomics and DiThera. Mr. Hosseini's skills in international medical device/diagnostic sales and marketing were developed at Abbott Laboratories, Ortho Clinical Diagnostics (Johnson & Johnson) and Sequenom, where he held executive and management positions in business development, and sales and marketing functions. He has 25+ years of extensive experience working with global biotech, pharmaceutical companies and healthcare providers. He received both his B.Sc. and MBA from the University of British Columbia.

 

Marisa Meloni Ph.D

CEO
VitroScreen

Marisa Meloni got a PhD in Drug Delivery and Cutaneous Bio-physic at Renée Descartes University, Paris V (France). Thereafter, she was in charge for research and innovation within the dermo-pharmaceutical and cosmetic industry for 15 years. During that period, she also was contract professor of safety assessment and technology of cosmetic products at Milan, Salerno and Padua Universities.

Marisa Meloni Ph.D

CEO
VitroScreen

Marisa Meloni Ph.D

CEO
VitroScreen

Marisa Meloni got a PhD in Drug Delivery and Cutaneous Bio-physic at Renée Descartes University, Paris V (France). Thereafter, she was in charge for research and innovation within the dermo-pharmaceutical and cosmetic industry for 15 years. During that period, she also was contract professor of safety assessment and technology of cosmetic products at Milan, Salerno and Padua Universities.

In 2001, she created VitroScreen, a research laboratory committed to in vitro science that has the mission to be a reference partner for companies approaching in vitro alternatives, providing in vitro pre-clinical efficacy and regulatory toxicological services.

At VitroScreen she has developed “mechanism based experimental models“ on 3D reconstructed human tissue models for active ingredients and finished product testing: this approach better mimics the in vivo skin and epithelia response taking into account the dynamic of the biological response. VitroScreen is GLP certified and a member of the EU-Netval national reference laboratory network.